Is Ultrasonography Comparable to MRI for the Detection of Morton Neuroma of the Foot?
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00284414 |
Recruitment Status :
Withdrawn
First Posted : January 31, 2006
Last Update Posted : May 19, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Patients with Morton neuroma of the foot will undergo either ultrasonography or MRI. The results will be compared.
In case of surgery, the pathology report will be compared with the ultrasonographic or MRI findings.
Which is the most reliable and specific: ultrasonography or MRI?
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Morton Neuroma | Procedure: Ultrasonography or MRI | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 40 participants |
Allocation: | Non-Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Is Ultrasonography Comparable to MRI for the Detection of Morton Neuroma of the Foot? |

- Reliability and specificity of ultrasonography and MRI for detection of Morton neuroma of the foot

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Morton neuroma of the foot
Exclusion Criteria:
-

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00284414
Principal Investigator: | Rene Verdonk, MD, PhD | University Hospital, Ghent |
Responsible Party: | René Verdonk, University Hospital Ghent |
ClinicalTrials.gov Identifier: | NCT00284414 |
Other Study ID Numbers: |
2004/199 |
First Posted: | January 31, 2006 Key Record Dates |
Last Update Posted: | May 19, 2009 |
Last Verified: | February 2009 |
Neuroma Morton Neuroma Nerve Sheath Neoplasms Neoplasms, Nerve Tissue Neoplasms by Histologic Type Neoplasms Metatarsalgia Foot Diseases |
Musculoskeletal Diseases Joint Diseases Neuralgia Peripheral Nervous System Diseases Neuromuscular Diseases Nervous System Diseases Pain Neurologic Manifestations |